Search
for
Sort by
Research 481–510 of 1000+
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- Oral ivermectin in the treatment of scabies
- Finasteride-associated cataract and intraoperative floppy-iris syndrome
- In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- History as a Tool in Identifying “New” Old Drugs
- 13C-NMR study of 4-azasteroids in solution and solid state
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men
- The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Finasteride: The First 5α-Reductase Inhibitor
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- Comparison of clinical trials with finasteride and dutasteride.
- Novel inhibitors of 5α-reductase
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Repeated finasteride administration induces depression-like behavior in adult male rats
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Therapeutic Androgen Receptor Ligands
- Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior